Disappointing Safety Data Rock Affymax; Hematide Path Unclear - BioWorld Online PDF Print
BioWorld OnlineInvestors hoping for a home run with the much-anticipated Phase III data of Hematide in chronic renal failure patients - including ...Affymax and Takeda Announce Phase 3 Trials Meet Primary Endpoints for

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.